Value of US Nuclear’s Part Ownership of Fusion Pioneer MIFTEC and MIFTI Should Soar
US Nuclear (OTC-QB: UCLE) is a strategic partner and investor in fusion energy companies MIFTEC and MIFTI. Approximately $2.8 billion has been invested in fusion energy over the last year, surpassing the previous decade's total of $2 billion. MIFTI's innovative Z-pinch fusion generator has achieved crucial milestones, aiming for net energy gain. This technology will aid MIFTEC in developing medical isotope generators to address a $10 billion annual shortage in the market. US Nuclear holds over 10% ownership in MIFTEC and a smaller stake in MIFTI.
- Investment in MIFTEC and MIFTI positions US Nuclear to benefit from the growing fusion energy market.
- Fusion sector attracted approximately $2.8 billion in investment over the past year, indicating strong industry interest.
- MIFTI's Z-pinch generator has achieved significant technical breakthroughs, potentially leading to net energy gain.
- MIFTEC’s technology aims to solve a critical $10 billion shortage in medical isotopes efficiently.
- None.
LOS ANGELES, CA, July 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – US Nuclear (OTC-QB: UCLE) is an investor, strategic partner, and likely prime contractor in fusion energy companies MIFTEC and MIFTI, and should see their investment in these companies soar, as both public and private money flows towards the fusion sector in the pursuit of unlimited, clean power. Over the past one year, approximately
The Fusion Energy Association reports that over
MIFTI is at the forefront of the fusion power generation revolution, and is set on achieving net energy gain for the first time in history. MIFTI’s unique, staged Z-pinch fusion generator has already achieved extraordinary success with their 1 MegaAmp machine demonstration, generating a neutron flux of over 1010 or 50 billion neutrons per pulse and achieving the required temperature, stability, and confinement time. Advanced simulations show that scaling up the generator to 10 MegaAmps will produce over 1,000 trillion neutrons per pulse, achieving net energy gain and enough neutrons for the commercial production of radioisotopes. MIFTEC will use this technology to build medical isotope generators in a fraction of the time and cost of current technology to help address the medical isotope market which has a devastating
US Nuclear owns over
Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com
CONTACT:
US Nuclear Corp. (OTC-QB: UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Richard Landry, Chief Financial Officer
(818) 883 7043
Email: info@usnuclearcorp.com
Usnuclearcorp.com
Tech-associates.com
overhoff.com
FAQ
What is the recent investment trend in fusion energy companies related to UCLE?
How does US Nuclear contribute to MIFTEC and MIFTI?
What technology breakthrough has MIFTI achieved?